Quantification of glutathione transverse relaxation time T 2 using echo time extension with variable refocusing selectivity and symmetry in the human brain at 7 Tesla-Reference-Cited by-同舟云学术

Quantification of glutathione transverse relaxation time T 2 using echo time extension with variable refocusing selectivity and symmetry in the human brain at 7 Tesla

Published:2018-05 Issue: Volume:290 Page:1-11
ISSN:1090-7807
Container-title:Journal of Magnetic Resonance
language:en
Short-container-title:Journal of Magnetic Resonance

Author:

Swanberg Kelley M.^ORCID,Prinsen Hetty,Coman Daniel,de Graaf Robin A.,Juchem Christoph

Funder

National Multiple Sclerosis Society

Publisher

Elsevier BV

Subject

Condensed Matter Physics,Nuclear and High Energy Physics,Biochemistry,Biophysics

Reference47 articles.

1. In Vivo NMR Spectroscopy: Principles and Techniques;de Graaf,2007

2. Glutathione S-transferase polymorphisms in MS: their relationship to disability;Mann;Neurology,2000

3. The role of oxidative stress in Parkinson's disease;Dias;J. Parkinson's Dis.,2013

4. The emerging role of glutathione in Alzheimer's disease;Saharan;J. Alzheimer's Dis.,2014

5. Implications for reactive oxygen species in schizophrenia pathogenesis;Koga;Schizophr. Res.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis and open-source database for in vivo brain Magnetic Resonance spectroscopy in health and disease;Analytical Biochemistry;2023-09

2. Meta-analysis and Open-source Database for In Vivo Brain Magnetic Resonance Spectroscopy in Health and Disease;2023-02-12

3. In vivo cortical glutathione response to oral fumarate therapy in relapsing-remitting multiple sclerosis: A single-arm open-label phase IV trial using 7-Tesla 1H MRS;NeuroImage: Clinical;2023

4. Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles;Scientific Reports;2022-08-16

5. In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing‐remitting multiple sclerosis;NMR in Biomedicine;2021-07-28